Sept 30 (Reuters) - Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including Bellus Health, Emerson Electric and Western Union on
Monday.
HIGHLIGHTS
* Apple Inc AAPL.O : JP Morgan establishes Dec 2020 PT of $265 vs Dec 2019 PT of $243
* Bellus Health Inc BLU.O : Jefferies initiates coverage with buy rating and $20 PT
* Emerson Electric Co EMR.N : RBC raises to outperform from sector perform
* Western Union Co WU.N : JP Morgan raises target price to $23 from $22
Following is a summary of research actions on U.S. companies reported by Reuters on Monday.
Stock entries are in alphabetical order.
* Accenture Plc ACN.N : Cowen and Company raises target price to $205 from $195
* Apple Inc AAPL.O : JP Morgan establishes Dec 2020 PT of $265 vs Dec 2019 PT of $243
* AT&T Inc T.N : Evercore ISI raises target price to $40 from $34
* Bellus Health Inc BLU.O : Jefferies initiates coverage with buy rating and $20 PT
* Brookfield Infrastructure Partners LP BIP.N : CIBC raises target price to $53 from $48
* CBOE Global Markets Inc CBOE.N : Jefferies raises target price to $110 from $105
* Deciphera Pharmaceuticals DCPH.O : Jefferies initiates with buy rating and $47 PT
* Edison International EIX.N : RBC raises target price to $79 from $76
* Emerson Electric Co EMR.N : RBC raises price target to $77 from $65
* Emerson Electric Co EMR.N : RBC raises to outperform from sector perform
* Granite Construction Inc GVA.N : Cowen and Company cuts target price to $50 from $65
* Seattle Genetics Inc SGEN.O : SVB Leerink raises target price to $102 from $87
* Vale SA VALE.N : Credit Suisse cuts target price to $16 from $18
* Western Union Co WU.N : JP Morgan raises target price to $23 from $22
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))